Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,104,131 papers from all fields of science
Search
Sign In
Create Free Account
KNTC1 gene
Known as:
kinetochore associated 1
, KNTC1
, KIAA0166
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
shRNA‑mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma.
Chuntao Liu
,
L. Min
,
Yong-jun Wang
,
P. Li
,
Yong-dong Wu
,
Shutian Zhang
International Journal of Oncology
2019
Corpus ID: 58553426
Kinetochore‑associated proteins are critical components of mitotic checkpoints, which are essential for faithful chromosomal…
Expand
2015
2015
Association between cell cycle gene transcription and tumor size in oral squamous cell carcinoma
M. G. Diniz
,
Jeane de Fátima Correia Silva
,
F. Souza
,
N. B. Pereira
,
C. Gomes
,
R. Gomez
Tumor Biology
2015
Corpus ID: 40688746
Higher tumor size correlates with poor prognosis and is an independent predictive survival factor in oral squamous cell carcinoma…
Expand
2010
2010
Novel somatic frameshift Mutations of Genes Related to Cell Cycle and DNA Damage Response in Gastric and Colorectal Cancers with Microsatellite Instability
Yoo Ri Kim
,
N. Chung
,
M. Kang
,
N. Yoo
,
S. Lee
Tumori
2010
Corpus ID: 11709017
Aims and background Microsatellite instability (MSI) in sporadic gastric cancer (GC) and colorectal cancer (CRC) causes…
Expand
2009
2009
Modulations of cell cycle checkpoints during HCV associated disease
Saira Sarfraz
,
S. Hamid
,
S. Ali
,
W. Jafri
,
A. Siddiqui
BMC Infectious Diseases
2009
Corpus ID: 16409840
BackgroundImpaired proliferation of hepatocytes has been reported in chronic Hepatitis C virus infection. Considering the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE